Delivery Order SPE2DB24D1021-SPE2DB24FESEL

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of NUCYNTA ER 100 mg tablets, with a total ceiling value of $1,388.98 and a period of performance through October 2024. The contract is a firm fixed-price delivery order, with no set-aside requirements indicated. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply NUCYNTA ER 100 MG TABLET 60S. The contract is a firm fixed-price delivery order with a ceiling value of $2,777.96 and a period of performance through July 25, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 200 MG TABLET 60S. The $10,839.70 contract has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 50 MG TABLET 60S. The contract is a firm fixed-price, delivery order contract with a ceiling value of $5,671.18 and an ultimate completion date of October 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NUCYNTA 100 MG TABLET 100S, a prescription pharmaceutical product. The contract has a firm fixed price of $4,535.72 and an ultimate completion date of September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this order as part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,555.73 contract is for the delivery of NUCYNTA ER 100 MG Tablets in 60-count packages. The award has an ultimate completion date of May 1, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NUCYNTA ER 200 MG TABLET 60S, a prescription pain medication. The contract has a ceiling value of $2,159.84 and a completion date of June 17, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 50 MG TABLET 60S. The contract has a ceiling value of $2,193.62 and is a firm fixed-price delivery order type, with a period of performance through May 5, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nucynta ER 200 mg tablets. The fixed-price contract has a ceiling value of $2,411.52 and a period of performance through June 6, 2025. The contract is not set-aside and is an open competition award. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NUCYNTA ER 250 MG TABLET 60S, a prescription medication. The contract has a ceiling value of $1,508.16 and a period of performance ending on April 21, 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FESEL
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 250 MG TABLET 60S. The contract has a ceiling value of $8,370.02 and a completion date of June 20, 2024. It is a firm fixed-price contract, and there is no set-aside designation noted. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order is likely part of the company's broader efforts to supply essential pharmaceutical products to the U.S. federal government and its various defense and healthcare programs.

Generated 11/1/24, 9:32 AM